Clinical Trial For Concussion Therapeutic on Recovery Now with Kim Justus

Dr. Michael Wyand is a biopharmaceutical executive with over 25yrs experience in managing and building successful product and service-oriented life science companies. He is the CEO and Director of Oxeia Biopharmaceuticals, a clinical-stage biotech company developing new, innovative therapeutics for mild traumatic brain injury (mTBI), known as concussion, and related neuro-metabolic dysfunction. Oxeia is actively recruiting participants for its ongoing Phase 2 clinical trial of OXE103 at the University of Kansas Medical Center. OXE103 could advance treatment directly addressing the underlying pathology of mTBI. An accomplished leader, Dr. Wyand has substantial experience managing R&D and as a corporate officer. He trained in comparative pathology at Harvard Medical School, received his DVM from Purdue University and his PhD in Pathology from the University of Connecticut. He received a BS in Biology from the University of Connecticut where he graduated with honors as a University Scholar. In second hour, Rico Petrini #49, an All-Conference Linebacker and Team MVP at Oregon State University, shares how he went from near perfect health to extreme  behavioral, neurological, and physical changes this past year at 49 years old and the clinical trial using Photobiomodulation that might have saved him. This show is a gathering place for anyone seeking recovery from the challenges of life on life's terms. We discuss useful tools that have helped us lighten the load of our journey through recovery. This is a we recovery program, because it is in the we that we find the new me. We focus on four A's of Recovery: Awareness, Acceptance, Action & Adaptation. This is a place for survivor's striving to become warriors! Host is Kim Justus, author of In a Flash: Miracles Here and Beyond  at inaflash.org & "Like" me at facebook.com/inaflash.org too!